FDA publishes four final guidances encouraging new sponsors of new animal drugs to pursue innovative ways to prepare and submit data for FDA evaluatio...
Federal Register notice: FDA makes available a draft guidance entitled S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals.
FDA warns Marci Beauty it is marketing seven unapproved light therapy devices.
FDA classifies as Class 1 a Medtronic recall of certain insulin pumps that was initiated to replace any pump that has a clear retainer ring due to pot...
Agilis Consulting names former FDA human factors team leader Shannon Hoste as president.
An FDA/HHS-funded University of Maryland study identifies factors that it says can lead to an uninterrupted supply of drugs for the U.S.
Johnson & Johnson files data to support an emergency use authorization for its Covid-19 booster shot in those 18 years of age and older.
FDA revises four guidance documents based on a final rule on the medical device de novo classification process.